Cinctive Capital Management LP cut its stake in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 38.1% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 73,674 shares of the company’s stock after selling 45,339 shares during the period. Cinctive Capital Management LP’s holdings in Waystar were worth $2,794,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC purchased a new position in Waystar in the third quarter worth approximately $25,000. ANTIPODES PARTNERS Ltd increased its position in shares of Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after purchasing an additional 449 shares during the last quarter. First Horizon Corp purchased a new stake in shares of Waystar in the 3rd quarter valued at approximately $38,000. EverSource Wealth Advisors LLC raised its holdings in shares of Waystar by 3,219.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock valued at $57,000 after purchasing an additional 1,352 shares in the last quarter. Finally, State of Wyoming lifted its position in shares of Waystar by 45.1% during the 2nd quarter. State of Wyoming now owns 2,098 shares of the company’s stock worth $86,000 after purchasing an additional 652 shares during the last quarter.
Waystar Trading Down 1.8%
NASDAQ WAY opened at $24.16 on Monday. The firm’s fifty day moving average price is $26.97 and its 200 day moving average price is $32.94. Waystar Holding Corp. has a 12 month low of $21.13 and a 12 month high of $42.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.41 and a quick ratio of 1.41. The company has a market capitalization of $4.63 billion, a price-to-earnings ratio of 39.61, a price-to-earnings-growth ratio of 0.94 and a beta of 0.80.
Insider Buying and Selling at Waystar
In other news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the business’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $30.08, for a total value of $1,209,968.00. Following the completion of the sale, the insider directly owned 474,826 shares of the company’s stock, valued at approximately $14,282,766.08. The trade was a 7.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.10% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the stock. The Goldman Sachs Group lowered their target price on shares of Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Weiss Ratings downgraded Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, March 10th. BMO Capital Markets lowered their price objective on Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, February 18th. Mizuho set a $42.00 price objective on Waystar in a report on Wednesday, February 4th. Finally, Zacks Research lowered Waystar from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 1st. Three analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $37.06.
Get Our Latest Stock Analysis on WAY
Waystar Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Articles
- Five stocks we like better than Waystar
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding WAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waystar Holding Corp. (NASDAQ:WAY – Free Report).
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
